Case Report

A Hepatic Encepholopathy Case By Abusing Synthetic Cannabinoid and Ecstasy

Volume: 2 Number: 1 April 30, 2022
  • Gamze Gokalp *
  • Tugce Nalbant
  • Yuksel Bıcılıoglu
  • Emel Berksoy
  • Sefika Bardak
  • Gulsah Demır
  • Alper Cıcek
Current Journal of Medical Research Cover
Current Journal of Medical Research
PDF Download
EN TR

A Hepatic Encepholopathy Case By Abusing Synthetic Cannabinoid and Ecstasy

Abstract

The increasing prevalence of illicit drugs abuse is a significant social and medical problem. This situation can cause various results, ranging from simple intoxication to fatal organ failure. The most common illicit is ecstasy (MDMA) and marijuana (cannabis). In this case report we tried to present a hepatic encephalopathy case due to using these drugs.

Keywords

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Case Report

Authors

Gamze Gokalp * This is me
0000-0002-0369-6379
Türkiye

Tugce Nalbant This is me
0000-0002-7408-2382
Türkiye

Yuksel Bıcılıoglu This is me
0000-0003-4531-3978
Türkiye

Sefika Bardak This is me
0000-0003-1211-6943
Türkiye

Gulsah Demır This is me
0000-0001-7841-4682
Türkiye

Publication Date

April 30, 2022

Submission Date

January 8, 2022

Acceptance Date

March 11, 2022

Published in Issue

Year 2022 Volume: 2 Number: 1

DOI

https://doi.org/10.52818/cjmr.v2i1.53

IZ

https://izlik.org/JA97ZC27GT

Cite

RIS / Bibtex
APA
Gokalp, G., Nalbant, T., Bıcılıoglu, Y., Berksoy, E., Bardak, S., Demır, G., & Cıcek, A. (2022). A Hepatic Encepholopathy Case By Abusing Synthetic Cannabinoid and Ecstasy. Güncel Tıbbi Araştırmaları Dergisi, 2(1), 9-11. https://doi.org/10.52818/cjmr.v2i1.53
AMA
1.Gokalp G, Nalbant T, Bıcılıoglu Y, et al. A Hepatic Encepholopathy Case By Abusing Synthetic Cannabinoid and Ecstasy. CJMR. 2022;2(1):9-11. doi:10.52818/cjmr.v2i1.53
Chicago
Gokalp, Gamze, Tugce Nalbant, Yuksel Bıcılıoglu, et al. 2022. “A Hepatic Encepholopathy Case By Abusing Synthetic Cannabinoid and Ecstasy”. Güncel Tıbbi Araştırmaları Dergisi 2 (1): 9-11. https://doi.org/10.52818/cjmr.v2i1.53.
EndNote
Gokalp G, Nalbant T, Bıcılıoglu Y, Berksoy E, Bardak S, Demır G, Cıcek A (April 1, 2022) A Hepatic Encepholopathy Case By Abusing Synthetic Cannabinoid and Ecstasy. Güncel Tıbbi Araştırmaları Dergisi 2 1 9–11.
IEEE
[1]G. Gokalp et al., “A Hepatic Encepholopathy Case By Abusing Synthetic Cannabinoid and Ecstasy”, CJMR, vol. 2, no. 1, pp. 9–11, Apr. 2022, doi: 10.52818/cjmr.v2i1.53.
ISNAD
Gokalp, Gamze - Nalbant, Tugce - Bıcılıoglu, Yuksel - Berksoy, Emel - Bardak, Sefika - Demır, Gulsah - Cıcek, Alper. “A Hepatic Encepholopathy Case By Abusing Synthetic Cannabinoid and Ecstasy”. Güncel Tıbbi Araştırmaları Dergisi 2/1 (April 1, 2022): 9-11. https://doi.org/10.52818/cjmr.v2i1.53.
JAMA
1.Gokalp G, Nalbant T, Bıcılıoglu Y, Berksoy E, Bardak S, Demır G, Cıcek A. A Hepatic Encepholopathy Case By Abusing Synthetic Cannabinoid and Ecstasy. CJMR. 2022;2:9–11.
MLA
Gokalp, Gamze, et al. “A Hepatic Encepholopathy Case By Abusing Synthetic Cannabinoid and Ecstasy”. Güncel Tıbbi Araştırmaları Dergisi, vol. 2, no. 1, Apr. 2022, pp. 9-11, doi:10.52818/cjmr.v2i1.53.
Vancouver
1.Gamze Gokalp, Tugce Nalbant, Yuksel Bıcılıoglu, Emel Berksoy, Sefika Bardak, Gulsah Demır, Alper Cıcek. A Hepatic Encepholopathy Case By Abusing Synthetic Cannabinoid and Ecstasy. CJMR. 2022 Apr. 1;2(1):9-11. doi:10.52818/cjmr.v2i1.53